莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603168 莎普爱思

已收盘 04-24 15:00:00

{"stockData":{"symbol":"603168","market":"SH","secType":"STK","nameCN":"莎普爱思","latestPrice":8.49,"timestamp":1713942000000,"preClose":8.48,"halted":0,"volume":5163840,"delay":0,"floatShares":323000000,"shares":379000000,"eps":0.0129,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"04-24 15:00:00","open":8.46,"high":8.51,"low":8.36,"amount":43599800,"amplitude":0.0177,"askPrice":8.5,"askSize":836,"bidPrice":8.49,"bidSize":270,"shortable":0,"etf":0,"ttmEps":0.0129,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714008600000},"adr":0,"adjPreClose":8.48,"symbolType":"stock","openAndCloseTimeList":[[1713922200000,1713929400000],[1713934800000,1713942000000]],"highLimit":9.33,"lowLimit":7.63,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":379161625,"pbRate":1.87,"roa":"--","roe":"1.48%","epsLYR":0.07,"committee":-0.100151,"marketValue":3219000000,"floatMarketCap":2739000000,"peRate":658.139513,"changeRate":0.0012,"turnoverRate":0.016,"status":0},"requestUrl":"/m/hq/s/603168","defaultTab":"news","newsList":[{"id":"2429847644","title":"莎普爱思(603168.SH)收到醋酸钠林格注射液药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429847644","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429847644?lang=zh_cn&edition=full","pubTime":"2024-04-24 16:59","pubTimestamp":1713949169,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，公司收到国家药品监督管理局核准签发的醋酸钠林格注射液《药品补充申请批准通知书》。醋酸钠林格注射液主要用于循环血容量及组织间液减少时细胞外液的补充，代谢性酸中毒的纠正。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108513.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429151596","title":"莎普爱思（603168）4月23日主力资金净买入10.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429151596","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429151596?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:16","pubTimestamp":1713856616,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月23日收盘，莎普爱思报收于8.48元，上涨3.54%，换手率2.54%，成交量8.19万手，成交额6857.13万元。4月23日的资金流向数据方面，主力资金净流入10.91万元，占总成交额0.16%，游资资金净流出149.79万元，占总成交额2.18%，散户资金净流入138.88万元，占总成交额2.03%。莎普爱思主营业务：从事药品研发、生产、销售及医疗服务。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300023159.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429052602","title":"莎普爱思去年销售费用达1.35亿元 同比增长45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429052602","media":"新京报网","top":-1,"share":"https://www.laohu8.com/m/news/2429052602?lang=zh_cn&edition=full","pubTime":"2024-04-21 12:04","pubTimestamp":1713672240,"startTime":"0","endTime":"0","summary":"新京报讯 4月20日，莎普爱思发布2023年年度报告，报告期内实现营业收入6.45亿元，同比增长17.37%；归属于上市公司股东的净利润为2540.76万元，同比下降43.23%。报告期内，莎普爱思加大对核心产品的推广力度，人员薪酬及宣传推广费增长金额较大。其中，销售费用达1.35亿元，同比增长45.09%。2023年，莎普爱思研发投入9124.83万元，同比增长53.06%，占营业收入的14.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404211206577921fa4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404211206577921fa4d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428642933","title":"莎普爱思(603168)3月31日股东户数3.75万户，较上期减少7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428642933","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428642933?lang=zh_cn&edition=full","pubTime":"2024-04-20 17:05","pubTimestamp":1713603913,"startTime":"0","endTime":"0","summary":"证券之星消息，近日莎普爱思披露，截至2024年3月31日公司股东户数为3.75万户，较12月31日减少2895.0户，减幅为7.17%。在化学制药行业个股中，莎普爱思股东户数高于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.37万户。从股价来看，2023年12月31日至2024年3月31日，莎普爱思区间跌幅为24.61%，在此期间股东户数减少2895.0户，减幅为7.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420170802879940cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420170802879940cb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428664988","title":"图解莎普爱思年报：第四季度单季净利润同比减10562.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428664988","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428664988?lang=zh_cn&edition=full","pubTime":"2024-04-20 00:46","pubTimestamp":1713545206,"startTime":"0","endTime":"0","summary":"证券之星消息，莎普爱思2023年年报显示，公司主营收入6.45亿元，同比上升17.37%；归母净利润2540.76万元，同比下降43.23%；扣非净利润-401.25万元，同比下降121.13%；其中2023年第四季度，公司单季度主营收入1.46亿元，同比上升8.18%；单季度归母净利润-5403.8万元，同比下降10562.44%；单季度扣非净利润-5975.72万元，同比下降576.35%；负债率20.32%，投资收益1370.52万元，财务费用118.62万元，毛利率55.98%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200056018b3bdd26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200056018b3bdd26&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428657044","title":"莎普爱思：4月18日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2428657044","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2428657044?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:04","pubTimestamp":1713535479,"startTime":"0","endTime":"0","summary":"每经AI快讯，莎普爱思 4月19日晚间发布公告称，公司第五届第二十六次董事会会议于2024年4月18日以现场及通讯方式召开。2023年1至12月份，莎普爱思的营业收入构成为：医药工业占比72.74%，诊疗服务占比26.18%。莎普爱思的总经理、董事长均是鄢标，男，42岁，学历背景为本科。截至发稿，莎普爱思市值为32亿元。道达号“个股趋势”提醒：1. 莎普爱思近30日内北向资金持股量未发生变化；2. 近30日内无机构对莎普爱思进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192213508796147b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192213508796147b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428652285","title":"莎普爱思(603168.SH)发布2023年度业绩，净利润2541万元，同比下降43.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428652285","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2428652285?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:49","pubTimestamp":1713534540,"startTime":"0","endTime":"0","summary":"莎普爱思披露2023年年度报告，公司2023年度实现营收6.45亿元，同比增长17.37%;归母净利润2541万元，同比下降43.23%;扣非净利润亏损401万元，同比由盈转亏;基本每股收益0.07元。公司拟每10股派发现金红利0.21元(含税)。报告期，公司实现营业收入64,497.02万元，较上年同期增加9,543.32万元，同比增长17.37%，主要系：公司采取了积极的市场拓展策略，加强品牌推广力度，布局医药新零售业务，滴眼液、头孢等品类销量稳步增长。股市回暖，抄底炒股先开户！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-19/doc-inaskrrs5182938.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-19/doc-inaskrrs5182938.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427845153","title":"莎普爱思：产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2427845153","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2427845153?lang=zh_cn&edition=full","pubTime":"2024-04-16 17:27","pubTimestamp":1713259620,"startTime":"0","endTime":"0","summary":"莎普爱思（SH 603168，收盘价：8.15元）4月16日晚间发布公告称，近日，浙江莎普爱思药业股份有限公司收到国家药品监督管理局核准签发的玻璃酸钠滴眼液的《药品注册证书》。产品名称为“玻璃酸钠滴眼液”。2022年1至12月份，莎普爱思的营业收入构成为：医药工业占比70.07%，诊疗服务占比28.15%。莎普爱思的董事长、总经理均是鄢标，男，42岁，学历背景为本科。截至发稿，莎普爱思市值为31亿元。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161730408b29dbbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161730408b29dbbb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427845158","title":"莎普爱思(603168.SH)获“玻璃酸钠滴眼液”药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2427845158","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2427845158?lang=zh_cn&edition=full","pubTime":"2024-04-16 17:14","pubTimestamp":1713258842,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)公告，近日，公司收到国家药品监督管理局核准签发的玻璃酸钠滴眼液的《药品注册证书》。该产品适应症为：伴随下述疾患的角结膜上皮损伤：干燥综合征、斯·约二氏综合征、干眼综合征等内因性疾患;手术后、药物性、外伤、配戴隐形眼镜等外因性疾患。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161718088b29ce53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161718088b29ce53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427977130","title":"莎普爱思大跌5.25% 主力净流出316万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427977130","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2427977130?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:44","pubTimestamp":1713145465,"startTime":"0","endTime":"0","summary":"04月15日，莎普爱思股价大幅下跌，截至09点44分，莎普爱思下跌5.25%，报8.84元/股，创近1月新低，成交2197万元，换手率0.73%。资金动向截止发稿，莎普爱思获得主力净流出316万元，其中超大单流出138万元，大单流出177万元。主营业务及业绩莎普爱思公司主营业务为滴眼液、大输液和头孢克肟等产品的研发、生产和销售。最新财报显示，今年三季报，莎普爱思实现营业收入4.99亿元，同比增长20.36%，净利润为7,944.56万元，同比增长75.54%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041510004279207214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041510004279207214&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425959791","title":"莎普爱思(603168.SH)：氟康唑氯化钠注射液通过仿制药质量和疗效一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2425959791","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2425959791?lang=zh_cn&edition=full","pubTime":"2024-04-08 15:45","pubTimestamp":1712562312,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司收到国家药品监督管理局核准签发的氟康唑氯化钠注射液《药品补充申请批准通知书》。经审查，该药品通过仿制药质量和疗效一致性评价。公司氟康唑氯化钠注射液通过仿制药质量和疗效一致性评价，有利于提升该产品市场竞争力，有利于扩大产品的市场销售，对公司的经营业绩产生积极的影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081547038afdae2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404081547038afdae2c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425693947","title":"莎普爱思大跌5.06% 主力净流出1527万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425693947","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2425693947?lang=zh_cn&edition=full","pubTime":"2024-04-08 14:14","pubTimestamp":1712556850,"startTime":"0","endTime":"0","summary":"04月08日，莎普爱思股价大幅下跌，截至14点14分，莎普爱思下跌5.06%，报9.38元/股，创近1月新低，成交1.12亿元，换手率3.65%。资金动向截止发稿，莎普爱思获得主力净流出1527万元，其中超大单流出1086万元，大单流出439万元。主营业务及业绩莎普爱思公司主营业务为滴眼液、大输液和头孢克肟等产品的研发、生产和销售。最新财报显示，今年三季报，莎普爱思实现营业收入4.99亿元，同比增长20.36%，净利润为7,944.56万元，同比增长75.54%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408141438791f1041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408141438791f1041&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424933063","title":"莎普爱思04月02日遭主力抛售551万元 环比增加387.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424933063","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424933063?lang=zh_cn&edition=full","pubTime":"2024-04-02 15:17","pubTimestamp":1712042268,"startTime":"0","endTime":"0","summary":"04月02日, 莎普爱思股价跌1.36%，报收10.18元，成交金额1.07亿元，换手率3.26%，振幅2.52%，量比0.64。莎普爱思今日主力资金净流出551万元，连续4日净流出，上一交易日主力净流出113万元，今日环比增加387.61%。近一年数据显示，该股主力连续4日净流出后，次日下跌概率为38.89%，平均跌幅为1.83%。该股近5个交易日上涨0.10%，主力资金累计净流出2135万元；近20日主力资金累计净流出5814万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040215235787d42e7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040215235787d42e7e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422958453","title":"莎普爱思：头孢克肟分散片获得药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2422958453","media":"21世纪经济报道","top":-1,"share":"https://www.laohu8.com/m/news/2422958453?lang=zh_cn&edition=full","pubTime":"2024-03-27 15:34","pubTimestamp":1711524840,"startTime":"0","endTime":"0","summary":"南方财经3月27日电，莎普爱思公告，头孢克肟分散片获得药品补充申请批准通知书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032715345387bb44df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032715345387bb44df&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422195534","title":"莎普爱思(603168.SH)：头孢克肟分散片视同通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2422195534","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422195534?lang=zh_cn&edition=full","pubTime":"2024-03-27 15:34","pubTimestamp":1711524840,"startTime":"0","endTime":"0","summary":"莎普爱思发布公告，近日，公司收到国家药品监督管理局核准签发的头孢克肟分散片《药品补充申请批准通知书》，经审查，本品视同通过仿制药质量和疗效一致性评价。截止目前，公司为国内第六家通过头孢克肟分散片一致性评价的企业。公司头孢克肟分散片视同通过仿制药一致性评价，有利于提升该产品市场竞争力，有利于扩大产品的市场销售，对公司的经营业绩产生积极的影响。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inaptzhr5528838.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inaptzhr5528838.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2421652938","title":"是否也有计划实施区块链技术？莎普爱思：公司无相关计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2421652938","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2421652938?lang=zh_cn&edition=full","pubTime":"2024-03-22 16:22","pubTimestamp":1711095721,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：据公开信息披露，贵公司行业内不少企业运营管理中都实施了区块链技术，是否对贵公司维系现有客户关系产生了新挑战？是否影响了贵公司的市场竞争优势？贵公司是否也有计划实施区块链技术？莎普爱思（603168.SH）3月22日在投资者互动平台表示，公司无相关计划。文章来源：每日经济新闻原标题：是否也有计划实施区块链技术？莎普爱思：公司无相关计划","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032216290987a63635&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032216290987a63635&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418306407","title":"莎普爱思03月12日获主力加仓7574万元 环比增加3281.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418306407","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418306407?lang=zh_cn&edition=full","pubTime":"2024-03-12 15:17","pubTimestamp":1710227870,"startTime":"0","endTime":"0","summary":"03月12日, 莎普爱思股价涨5.52%，报收10.33元，成交金额5.41亿元，换手率15.96%，振幅11.13%，量比3.47。莎普爱思今日主力资金净流入7574万元，连续3日净流入，上一交易日主力净流入224万元，今日环比增加3281.25%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为25.00%，平均涨幅为8.29%。该股近5个交易日上涨8.97%，主力资金累计净流入6203万元；近20日主力资金累计净流出352万元，其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403121523358775a339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403121523358775a339&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418323717","title":"异动快报：莎普爱思（603168）3月12日9点40分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2418323717","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2418323717?lang=zh_cn&edition=full","pubTime":"2024-03-12 09:46","pubTimestamp":1710207960,"startTime":"0","endTime":"0","summary":"证券之星3月12日盘中消息，9点40分莎普爱思触及涨停板。目前价格10.77，上涨10.01%。该股为眼科，医药，民营医院概念热股，当日眼科概念上涨2.66%，医药概念上涨2.3%，民营医院概念上涨1.68%。近5日资金流向一览见下表：莎普爱思主要指标及行业内排名如下：以上内容由证券之星根据公开信息整理，由算法生成，与本站立场无关。证券之星力求但不保证该信息全部或者部分内容的的准确性、完整性、有效性、及时性等，如存在问题请联系我们。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031209471987746e7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031209471987746e7c&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-07-02","address":"浙江省嘉兴市平湖市经济开发区新明路1588号","stockEarnings":[{"period":"1week","weight":-0.0363},{"period":"1month","weight":-0.1493},{"period":"3month","weight":-0.2572},{"period":"6month","weight":-0.2175},{"period":"1year","weight":-0.0597},{"period":"ytd","weight":-0.3669}],"companyName":"浙江莎普爱思药业股份有限公司","boardCode":"AI0027","perCapita":"8608股","boardName":"医药制造业","registeredCapital":"37916万元","compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0477},{"period":"6month","weight":0.009},{"period":"1year","weight":-0.0674},{"period":"ytd","weight":0.0235}],"survey":"　　浙江莎普爱思药业股份有限公司主营业务为医药制造板块以及医疗服务板块。主要产品为苄达赖氨酸滴眼液、大输液、头孢克肟、诊疗服务。公司核心产品莎普爱思滴眼液属于眼科用药(抗白内障类)领域。公司利用营销网络优势,为莎普爱思滴眼液树立了良好的品牌和知名度,在国内白内障药物市场中处于行业前列。根据北京东方比特科技有限公司《中国白内障滴眼液市场研究报告》数据显示,2019年公司莎普爱思滴眼液在我国白内障用药市场份额为21.51%。","serverTime":1714005450897,"listedPrice":21.85,"stockholders":"37475人(较上一季度减少7.17%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莎普爱思,603168,莎普爱思股票,莎普爱思股票老虎,莎普爱思股票老虎国际,莎普爱思行情,莎普爱思股票行情,莎普爱思股价,莎普爱思股市,莎普爱思股票价格,莎普爱思股票交易,莎普爱思股票购买,莎普爱思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}